Ferroptosis: Newly Emerged Regulator for Human Disease
Authors:
Open Access
Abstract
Ferroptosis is a novel, iron‐driven form of cell death characterized by iron‐dependent membrane‐lipid peroxidation. Accumulating evidence has revealed that ferroptosis is heavily involved in multiple physiological and pathological conditions, resulting in remarkable progress in the treatment of multiple diseases. This review summarizes recent advances in and the fundamental features of ferroptosis and outlines the molecular mechanisms that regulate core metabolic pathways and their relevance to cellular physiology. In addition, the mechanisms and functional implications of ferroptosis in cancer, cardiovascular diseases, neurodegenerative disorders, and acute organ injury are discussed, and current diagnostic and therapeutic strategies that target ferroptosis are summarized. Finally, the review identifies persistent gaps in the mechanistic understanding, relevant biomarker development, and translational validity of ferroptosis to provide a comprehensive foundation for future research and clinical innovation in the era of precision medicine.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2025QC353)
This publication has 339 references indexed in Scilit:
- Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic StrategiesMedcomm, 2025
- Iridium(III) Photosensitizers Induce Simultaneous Pyroptosis and Ferroptosis for Multi‐Network Synergistic Tumor ImmunotherapyAngewandte Chemie International Edition, 2024
- Antiferroptosis therapy alleviated the development of atherosclerosisMedcomm, 2024
- Metal‐Organic Framework‐Based Nanomedicines for Ferroptotic Cancer TherapyAdvanced Healthcare Materials, 2024
- Ferroptosis Detection: From Approaches to ApplicationsAngewandte Chemie International Edition, 2023
- First‐in‐Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15‐Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral SclerosisClinical Pharmacology in Drug Development, 2022
- Fe(III)‐Shikonin Supramolecular Nanomedicine for Combined Therapy of Tumor via Ferroptosis and NecroptosisAdvanced Healthcare Materials, 2021
- The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis2021
- Acetaminophen sensitizing erastin‐induced ferroptosis via modulation of Nrf2/heme oxygenase‐1 signaling pathway in non‐small‐cell lung cancerJournal of Cellular Physiology, 2019
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015